Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Petr Stepka"'
Autor:
Jan Balvan, Jaromir Gumulec, Martina Raudenska, Aneta Krizova, Petr Stepka, Petr Babula, Rene Kizek, Vojtech Adam, Michal Masarik
Publikováno v:
PLoS ONE, Vol 10, Iss 12, p e0145016 (2015)
Resistant cancer phenotype is a key obstacle in the successful therapy of prostate cancer. The primary aim of our study was to explore resistance mechanisms in the advanced type of prostate cancer cells (PC-3) and to clarify the role of autophagy in
Externí odkaz:
https://doaj.org/article/97d13d69b9f5426d8ce681cb3763bb60
Publikováno v:
Current Medicinal Chemistry. 28:1270-1289
Metabolic changes driven by the hostile tumor microenvironment surrounding cancer cells and the effect of these changes on tumorigenesis and metastatic potential have been known for a long time. The usual point of interest is glucose and changes in i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3275c35b88951f45bb7e835f4891a2c
https://doi.org/10.2174/0929867327666200207114658
https://doi.org/10.2174/0929867327666200207114658
Autor:
Adam Weiser, A. Dlouhy, Petr Stepka, Monika Pávková Goldbergová, Denisa Bartkova, Jana Veverková, Petr Babula
Publikováno v:
Environmental Science and Pollution Research. 27:7934-7942
Nickel-titanium alloys have been used in medical applications for several years; however, biocompatibility of the material remains controversial. In the present study, the human umbilical vein endothelial cells (HUVEC) were cultured in contact with t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f62d0abe56ac6ec1b63a14928d801ac7
https://doi.org/10.1007/s11356-019-07506-8
https://doi.org/10.1007/s11356-019-07506-8
Autor:
Monika Kratochvílová, Michal Masarik, Tomáš Vaculovič, Martina Raudenská, Petr Stepka, Hana Polanska, Michaela Kuchynka, Tomas Vicar, Marketa Vaculovicova
Publikováno v:
BioMed Research International, Vol 2021 (2021)
BioMed Research International. 2021, vol. 2021, issue 1, p. 1-8.
BioMed Research International
BioMed Research International. 2021, vol. 2021, issue 1, p. 1-8.
BioMed Research International
The main dose-limiting side effect of cisplatin is nephrotoxicity. The utilization of cisplatin is an issue of balancing tumour toxicity versus platinum-induced nephrotoxicity. In this study, we focused on intraorgan distribution of common essential
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24eb38242c8762018c7dc025a7645406
https://doaj.org/article/5951b902bd594c7c88c9ddc31b538450
https://doaj.org/article/5951b902bd594c7c88c9ddc31b538450
Autor:
Petr Stepka, Jaromír Gumulec, Michal Masarik, René Kizek, Aneta Krizova, Vojtech Adam, Martina Raudenská, Petr Babula, Jan Balvan
Publikováno v:
PLOS ONE. 2015, vol. 10, issue 12, p. 1-23.
PLoS ONE
PLoS ONE, Vol 10, Iss 12, p e0145016 (2015)
PLoS ONE
PLoS ONE, Vol 10, Iss 12, p e0145016 (2015)
Resistant cancer phenotype is a key obstacle in the successful therapy of prostate cancer. The primary aim of our study was to explore resistance mechanisms in the advanced type of prostate cancer cells (PC-3) and to clarify the role of autophagy in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91516a47431ad577ecde061274511d61
https://doi.org/10.1371/journal.pone.0145016
https://doi.org/10.1371/journal.pone.0145016